skip to Main Content
No items found

Recorded Webinars

Medication Management Reform: How We Integrate Technology

Webinar Date: August 26, 2020

Molly Ekstrand, BPharm, BCACP, AE-C, Consultant with North Star Medication Optimization, LLC, along with Jane Gilbert, CPA, Director of Retiree Health Care, Teachers Retirement System of the State of Kentucky, offer an overview of how health care IT infrastructure can efficiently enable health systems, payers and purchasers of health care to identify groups of patients who will most likely benefit from comprehensive medication management services.

Hear more about using a risk stratification process for patient identification to select individuals that benefit most from comprehensive medication management services intended to produce value-based outcomes: economic, humanistic and clinical.  There will also be discussion about why it is vital for regulators, care providers and payers to work together to establish standards and best practices to ensure access to clinical information, to include diagnostics, at the point of care.

This webinar will also showcase a case example of risk stratification in action with the Teachers Retirement System in Kentucky.


At the close of this activity, participants will be able to:

  • Explain what is needed within organizations to leverage health IT to enable comprehensive medication management (CMM).
  • Discuss use of data aggregation tools today and where they need to evolve to support medication optimization and the CMM process.
  • Explain what data and information is needed to inform CMM programs for patients and their care team for effective and accurate clinical decision making.
  • Discuss the health IT capabilities and functionalities supporting CMM practice to include risk stratification to identify those at risk of not meeting clinical goals of therapy and how CMM services can then help optimize medications for improved outcomes.
  • Discuss how the CMM process was informed by PGx for a retiree population.


Speakers

Molly J. Ekstrand, BPharm, BCACP, AE-C

Principal Consultant
North Star Medication Optimization, LLC

Jane Cheshire Gilbert, CPA

Director, Retiree Health Care
Teachers’ Retirement System of the State of Kentucky (TRS)
Read More

Medication Management Reform: How We Practice

Webinar Date: July 22, 2020

Join Paul Grundy, M.D., MPH, FACOEM, FACPM, chief transformation officer of Innovaccer and president of the GTMRx Institute; Todd Sorensen, Pharm.D., FAPhA, FCCP, associate dean for strategic initiatives and innovations, Department of Pharmaceutical Care and Health Systems at the University of Minnesota; and Kylee Funk, Pharm.D., BCPS, associate professor, University of Minnesota College of Pharmacy, as they offer an overview of actions that providers can take in their practice in order to assist in the implementation of comprehensive medication management.

Optimal patient care cannot happen without a systematic approach to medication use, and that will require significant structural changes. This webinar will give insight into making the case for medication management reform and focus primarily on practice and care delivery to outline how providers can enhance the patient experience, improve population health, reduce costs and, for primary care, bring back the joy in practicing medicine.


Speakers

Todd Sorensen, Pharm.D.

Professor and Associate Dean for Strategic Initiatives and Innovation
College of Pharmacy, University of Minnesota

Kylee Funk, PharmD

Associate Professor
University of Minnesota College of Pharmacy
Read More

Pharmacogenomics: What you need to know during COVID-19 and lessons learned from implementation in team-based care

Webinar Date: June 9, 2020

Pharmacogenetics and pharmacogenomics (PGx) are trending as important fields for targeting correct therapies. Pharmacogenomics testing is an important tool to ensure a personalized approach to medication use not only today but in the future.

It makes sense that evaluation of a patient’s genotype can support the clinical decision-making process, improving patient outcomes. So, why are advances made at the bench not reaching the bedside? What are the barriers we need to overcome? Further, how do we incorporate PGx into team-based care, and how can PGx aid in treatment decisions for COVID-19 patients? This webinar will explore PGx with overviews from two recently published articles.

Hear from a clinical pharmacist and a research consultant as they discuss findings from two separate research studies on pharmacogenomics. Colleen Keenan, a consultant with The Advisory Board’s Clinical Innovators Council, will share findings from her recent paper, “Considering pharmacogenomics during COVID-19? Here’s what you need to know.” And Emily J. Cicali, Pharm.D., BCPS, clinical associate professor at the University of Florida, College of Pharmacy, shares highlights from her recent PCORI-funded publication, “Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.”

Some of the questions we’ll address include:

  • How are PGx practice activities implemented and impacted during COVID-19?
  • In the post-pandemic environment, what will likely be the realities of team-based, person-centered care using PGx as a tool to support CMM?
  • What are the barriers to implementation of PGx in team-based care in an ambulatory care setting?
  • What are important process-of-care lessons learned during COVID-19?
  • How will lessons learned from implementing team-based PGx in ambulatory care settings help shape future PGx clinical trials and clinical implementations?
  • And more…


Speakers

Emily J. Cicali, Pharm.D., BCPS

Clinical Assistant Professor
University of Florida, College of Pharmacy
Colleen Keenan photo

Colleen Keenan

Consultant
The Advisory Board
Read More

Telehealth during COVID-19: Opportunity to expand access to comprehensive medication management?

Webinar Date: May 28, 2020

The COVID-19 global health care crisis has created a real opportunity to expand access to care through telehealth. How do we optimize patient outcomes and ensure appropriate use of medications virtually?

In recent weeks commercial and public payors have increasingly extended coverage, and health systems are mobilizing quickly to expand programs to meet the rapid increase in demand for services. The coronavirus emergency supplemental legislation has expanded Medicare coverage of telehealth.

Hear from a clinical pharmacist and a policy analyst as they discuss barriers to implementation and opportunities that the coronavirus pandemic offers to expand telehealth services. They will consider in what way these changes may impact care delivery.

Tune in to hear more about:

  • Coronavirus emergency supplemental legislation—what does this mean in terms of access, coverage and expansion of telehealth services?
  • How has telemedicine use changed during the pandemic; what services are being virtualized?
  • What do we expect to see in terms of regulatory shifts, and how will this change the way telehealth is provided in the future?
  • How does telehealth provide a path to interprofessional care teams working collaboratively to optimize medication use?
  • Beyond COVID-19, what are some of the key considerations for implementation, evaluation and coverage of CMM services in telehealth practices?


Additional Resources:

“A Framework for Evaluating the ROI of Telehealth”

“Opportunities To Expand Telehealth Use Amid The Coronavirus Pandemic,” Health Affairs, 16 March 2020

Implementation and evaluation of comprehensive medication management in telehealth practices” Journal of American Clinical Pharmacy, January 2020


Speakers

Melissa Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, AAHIVP

Clinical Associate Professor, Section of Infectious Diseases Pharmacotherapy
University of Illinois at Chicago, College of Pharmacy

Jared Augenstein, MA, MPH

Director
Manatt, Phelps & Phillips, LLP
Read More

Live Panel Discussion | Get the Medications Right: Innovations in Team-Based Care

Webinar Date: February 6, 2020

Why this? Why now?

The goal of the GTMRx Institute is to ensure appropriate and personalized use of medication and gene therapies by advancing to a scientific, evidence-based and cost-effective decision-making process and a team-based, systematic approach to medication use. We believe this will offer consumers a personalized approach to medication use. For those who pay for care, it will create a reduction in total cost of care—saving lives and saving money.

Critical to this goal is our work sponsoring and supporting multi-stakeholder activities that will encourage practice transformation, create pathways for dissemination of evidence and innovation and encourage payment and policy reform.

At our February summit we discussed how we can harness and scale what we know works from the decades of work happening across health care to integrate medication experts into the care team and to facilitate “whole-person” medication use. We examined what we can do to fix the trial-and-error approach to medication use that’s costing 275,000 people their lives and $528 billion in waste that we all pay for.

If you missed the live Bipartisan Policy Center and GTMRx Institute event, the recording is available and features:

Katherine Herring Capps
Executive Director and Co-founder, GTMRx

Carolyn Clancy, M.D.
Deputy Under Secretary for Discovery, Education and Affiliate Networks, Veterans Health Administration

Susan Dentzer, M.P.H.
Senior Policy Fellow, Robert J. Margolis Center of Health Policy, Duke University

Gregory Downing, DO, Ph.D.
Founder, Innovation Horizons, LLC, & Co-Chair of Health Datapalooza

Elizabeth Fowler, J.D., Ph.D.
Executive Vice President of Programs, Commonwealth Fund

Gerard A. Greskovic, RPh, CACP, CDE
System Director, Ambulatory Pharmacy Programs, Enterprise Pharmacy
Clinical Instructor of Pharmacy at Geisinger Commonwealth School of Medicine

Anand Parekh, M.D.
Chief Medical Advisor, Bipartisan Policy Center

Dan Rehrauer, PharmD
Senior Manager, Medication Therapy Management Program, HealthPartners


No items found
Read More

Live Opening Remarks and Discussion | Get the Medications Right: Innovations in Team-Based Care

Webinar Date: February 6, 2020

Why this? Why now?

The goal of the GTMRx Institute is to ensure appropriate and personalized use of medication and gene therapies by advancing to a scientific, evidence-based and cost-effective decision-making process and a team-based, systematic approach to medication use. We believe this will offer consumers a personalized approach to medication use. For those who pay for care, it will create a reduction in total cost of care—saving lives and saving money.

Critical to this goal is our work sponsoring and supporting multi-stakeholder activities that will encourage practice transformation, create pathways for dissemination of evidence and innovation and encourage payment and policy reform.

At our February summit we discussed how we can harness and scale what we know works from the decades of work happening across health care to integrate medication experts into the care team and to facilitate “whole-person” medication use. We examined what we can do to fix the trial-and-error approach to medication use that’s costing 275,000 people their lives and $528 billion in waste that we all pay for.

If you missed the live Bipartisan Policy Center and GTMRx Institute event, the recording is available and features:

Katherine Herring Capps
Executive Director and Co-founder, GTMRx

Carolyn Clancy, M.D.
Deputy Under Secretary for Discovery, Education and Affiliate Networks, Veterans Health Administration

Susan Dentzer, M.P.H.
Senior Policy Fellow, Robert J. Margolis Center of Health Policy, Duke University

Gregory Downing, DO, Ph.D.
Founder, Innovation Horizons, LLC, & Co-Chair of Health Datapalooza

Elizabeth Fowler, J.D., Ph.D.
Executive Vice President of Programs, Commonwealth Fund

Gerard A. Greskovic, RPh, CACP, CDE
System Director, Ambulatory Pharmacy Programs, Enterprise Pharmacy
Clinical Instructor of Pharmacy at Geisinger Commonwealth School of Medicine

Anand Parekh, M.D.
Chief Medical Advisor, Bipartisan Policy Center

Dan Rehrauer, PharmD
Senior Manager, Medication Therapy Management Program, HealthPartners


No items found
Read More

Interoperability Forecast: Opportunities & Solutions for Comprehensive Medication Management

Webinar Date: October 29, 2019

Earlier this year, The Centers for Medicare and Medicaid Services and the Office of the National Coordinator released their proposed new regulations to advance interoperability across the health care system and to make it easier for patients and caregivers to access their personal health information. The proposed regulations would have significant implications for how health plans, providers and others handling patient data format, exchange and use health care data. In addition to government-led initiatives, market players are moving forward with their own data and technology transformation strategies, alliances and product development efforts.

This webinar provides a view of developments in healthIT through the lens of our ability to provide a single view of patient care that is necessary to enable a person-centered approach to medication use to ensure appropriate use of medications and gene therapies.

Featuring the voices of Deb Gage, president and CEO at Medecision and GTMRx Institute board member, Lisa Bari, former health IT and interoperability lead at the Centers for Medicare and Medicaid Services’ (CMS) Innovation Center and Ryan Howells, principal at Leavitt Partners and lead at the CARIN Alliance.


Speakers

Ryan Howells

Ryan Howells, M.H.A., PMP

Principal
Leavitt Partners

Lisa Bari

Consultant
Health Care IT Policy Consulting, LLC
Deb Gage

Deborah M. Gage, MBA

President and CEO
Medecision
Read More

Core tenets to implement CMM in primary care: Getting the medications right

Webinar Date: September 26, 2019

Comprehensive medication management (CMM) is a systematic approach to ensuring all medications are safe, effective and appropriate for the patient. But operationalizing CMM into team-based primary care delivery takes a systematic approach, too. This webinar offers a customizable blueprint for delivery of CMM and demonstrates how it improves work-life balance for primary care providers. It includes strategies learned from practices in the field and showcases research-based tools practices can use to implement CMM.

Featuring the voices of Mary Roth McClurg, Pharm.D., MHS, professor and executive vice dean-chief academic officer at the UNC Eshelman School of Pharmacy and Ed Webb, Pharm.D., MPH, FCCP, GTMRx Institute board member and senior policy advisor to the executive director and Board of Regents of the American College of Clinical Pharmacy.


Speakers

Todd Sorensen, Pharm.D.

Professor and Associate Dean for Strategic Initiatives and Innovation
College of Pharmacy, University of Minnesota

Mary Roth McClurg, Pharm.D, MHS

Professor and Executive Vice Dean-Chief Academic Officer
UNC Eshelman School of Pharmacy
Ed Webb

C. Edwin Webb, Pharm.D., MPH, FCCP (Pharmacist)

Senior Policy Advisor to the Executive Director and Board of Regents
American College of Clinical Pharmacy (ACCP)
Read More

Pharmacogenomics: Lowering costs, improving outcomes through personalized medicine

Webinar Date: August 7, 2019

Pharmacogenomics considers the role of the genome in drug response. It combines pharmacology and genomics, considering how the genetic makeup of an individual affects his/her response to drugs.

Today, more than ever before, we have the ability to target the right drug to improve a patient’s quality of life while also eliminating waste from non-optimized medications. This webinar provided an overview of pharmacogenomics and showcased an employer case example of the opportunities and savings available to employers and health plans through integration of personalized medicine into benefit plan design.

Featuring the voices of Jane Cheshire Gilbert, CPA, director of retiree health care for the Teachers’ Retirement System of the State of Kentucky and Steve Goldberg, MD, vice president, medical affairs, population health and chief health officer, health & wellness, Quest Diagnostics, GTMRx Institute board member.


Speakers

Steven Goldberg

Steven Goldberg, MD, MBA

VP, Medical Affairs, Population Health, Chief Health Officer, Health and Wellness
Quest Diagnostics

Jane Cheshire Gilbert, CPA

Director, Retiree Health Care
Teachers’ Retirement System of the State of Kentucky (TRS)
Read More

CMM Practice in Real Time: Clinical pharmacy specialists on the VA care team

Webinar Date: June 19, 2019

Comprehensive medication management is a team sport, with the potential to improve patient care and access while optimizing the skills of all clinicians on the team. The Veterans Health Administration has systematically integrated clinical pharmacy specialists into the care team to accomplish CMM for a range of chronic conditions. In this webinar, we explore the practice model and outcomes of CMM integration, as well as the tools that support the team.

Featuring the voices of Anthony P. Morreale, Pharm.D., MBA, BCPS, FASHP, associate chief consultant for clinical pharmacy and policy for the Department of Veterans Affairs Pharmacy Benefits Management in VA Central Office, Julie Groppi, Pharm.D., FASHP, national PBM program manager for clinical pharmacy practice policy and standards for VA Central Office and Brig. Gen. Allison Hickey (Ret.) USAF, former undersecretary of the Veterans Benefits Administration, CEO and founder of All In Solutions LLC and GTMRx Institute founding board member.


Speakers

Julie Groppi

Julie Groppi, Pharm.D., FASHP

PBM Program Manager for Clinical Pharmacy Practice Policy and Standards
VA Central Office

Brig. Gen. Allison Hickey

Chief Executive Officer
All In Solutions LLC
Anthony Morreale

Anthony P. Morreale, Pharm.D., MBA, BCPS, FASHP

Associate Chief Consultant for Clinical Pharmacy and Policy
Department of Veterans Affairs Pharmacy Benefits Management
Read More

Acting on the $528 Billion Opportunity: Training to Advance Comprehensive Medication Management in Practice

Webinar Date: May 14, 2019

Comprehensive medication management (CMM) is recommended as a solution to the problem of non-optimized medication use. This systematic approach to medications is a means to significantly improve clinical outcomes and reduce overall health care costs for high-risk patients. This webinar explored the need for CMM and implications for pharmacy education and training, as well as how CMM is integrated into team-based care models.

Featuring the voices of Terry McInnis, MD, MPH, president and co-founder, Get the Medications Right Institute and Foundation; president, founder, Blue Thorn Inc.; and Jan Hirsch, BS Pharm, Ph.D., director and founding dean, Pharmaceutical Sciences University of California, Irvine.


Speakers

Terry McInnis, MD, MPH

President
Blue Thorn Inc.
Jan Hirsch

Jan Hirsch, BS Pharm, Ph.D.

Director and Founding Dean, Pharmaceutical Sciences
University of California, Irvine
Read More

The $528 Billion Opportunity

Webinar Date: April 30, 2019

Employers, health plans and consumers have made the rising cost of medications a priority. But when medications aren’t appropriate, effective and safe, the human and dollar costs mount even higher. Research published in 2018 demonstrates the morbidity and mortality related to non-optimized medication use totals $528 billion a year. In this webinar, join two of that study’s co-authors to explore the direct costs adding up to a $528 billion opportunity to reduce overall costs of care and why the authors believe comprehensive medication management integration offers a viable, cost-effective, scalable solution.

Featuring the voices of Terry McInnis, MD, MPH, president and co-founder, Get the Medications Right Institute and Foundation; president, founder, Blue Thorn Inc.; and Jonathan H. Watanabe, Pharm.D., M.S., Ph.D. BCGP, associate professor of clinical pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego.


Speakers

Terry McInnis, MD, MPH

President
Blue Thorn Inc.
Jonathan H. Watanabe

Jonathan H. Watanabe, Pharm.D., M.S., Ph.D. BCGP

Associate Professor of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Read More
Back To Top
×Close search
Search